{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:04:05Z","timestamp":1794265445513,"version":"4.9.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Liver cancer continues to pose a global health challenge. In 2020, China accounted for nearly half of new liver cancer cases worldwide, with a low 5-year survival. This study aims to evaluate the evolving landscape of the liver cancer burden in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data on prevalence, incidence, death, and disability-adjusted life year (DALY) attributed to liver cancer and its six etiologies in China between 1990 and 2021 were extracted from the Global Burden of Disease Study 2021. Temporal trends in liver cancer burden were determined by percent changes and average annual percent change (AAPC). Decomposition analysis was conducted to understand the contributions of population aging, population growth, and epidemiological change to the observed trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, there were 265,539 prevalence cases of liver cancer in China accounting for 35.9% of the global total (739,300 prevalence cases). From 1990 to 2021, the prevalence cases, incidence cases, deaths, and DALYs attributed to liver cancer in China increased by 99.99%, 103.91%, 81.24%, and 48.41%, respectively, primarily driven by population aging, then population growth. Males experienced higher burden and percentage changes in prevalence, incidence, and DALYs than females. Meanwhile, decreasing trends were observed in overall age-standardized incidence, death, and DALY rates (AAPC: \u20130.32%, \u20130.79%, and \u20131.03%) and generally across sex groups and the six etiologies. Notably, there were increasing trends in age-standardized incidence rate of liver cancer due to alcohol use (AAPC: 0.36%) and metabolic dysfunction-associated steatotic liver disease (MASLD) (AAPC: 0.44%). In 2021, hepatitis B, hepatitis C, and alcohol use were the main causes of liver cancer burden in China. There were age differences in the burden of liver cancer. The overall 5-year relative survival rate was 12.27% in 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Liver cancer cases increased dramatically over the past 30 years, primarily driven by population aging and growth, posing challenges to the control of liver cancer. Targeted interventions by sex, etiology, and age are needed to address the burden effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003828","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T21:00:09Z","timestamp":1767387609000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Burden of liver cancer and underlying etiologies in China from 1990 to 2021: A systematic analysis from the Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"139","author":[{"given":"Menglong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"He","sequence":"additional","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan M.","family":"Khattab","sequence":"additional","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galal","family":"Elshishiney","sequence":"additional","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[{"name":"Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China"},{"name":"UNESCO Chair on Global Health and Education, Peking University, Beijing 100083, China"},{"name":"Beijing Key Laboratory of Environment and Aging, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"R1-20260205","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","article-title":"Liver cancer in 2021: Global Burden of Disease Study","volume":"82","author":"Tan","year":"2025","journal-title":"J Hepatol"},{"key":"R3-20260205","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20260205","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"R5-20260205","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/CM9.0000000000003140","article-title":"Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022","volume":"137","author":"Cao","year":"2024","journal-title":"Chin Med J"},{"key":"R6-20260205","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/CM9.0000000000003171","article-title":"Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study","volume":"137","author":"Xu","year":"2024","journal-title":"Chin Med J"},{"key":"R7-20260205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20260205","first-page":"679","article-title":"Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: Profiles and changing trends","volume":"21","author":"Cao","year":"2024","journal-title":"Cancer Biol Med"},{"key":"R9-20260205","first-page":"203","article-title":"Cancer survival statistics in China 2019\u20132021: A multicenter, population-based study","volume":"4","author":"Zeng","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R10-20260205","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12885-024-12334-2","article-title":"Liver cancer in China: The analysis of mortality and burden of disease trends from 2008 to 2021","volume":"24","author":"Qin","year":"2024","journal-title":"BMC Cancer"},{"key":"R11-20260205","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","article-title":"Incidence of etiology-specific hepatocellular carcinoma: Diverging trends and significant heterogeneity by race and ethnicity","volume":"22","author":"Pinheiro","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-20260205","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/cam4.4551","article-title":"Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"R13-20260205","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7891574","article-title":"Oxidative stress and liver cancer: Etiology and therapeutic targets","volume":"2016","author":"Wang","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"R14-20260205","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"R15-20260205","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"R16-20260205","doi-asserted-by":"crossref","first-page":"554","DOI":"10.21147\/j.issn.1000-9604.2022.06.02","article-title":"Burden of liver cancer: From epidemiology to prevention","volume":"34","author":"Li","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"R17-20260205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ijc.33313","article-title":"Is it possible to halve the incidence of liver cancer in China by 2050?","volume":"148","author":"Shi","year":"2021","journal-title":"Int J Cancer"},{"key":"R18-20260205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2021.02.017","article-title":"Cancer screening in China: The current status, challenges, and suggestions","volume":"506","author":"Cao","year":"2021","journal-title":"Cancer Lett"},{"key":"R20-20260205","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R21-20260205","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R22-20260205","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: A forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R23-20260205","article-title":"Subnational Evidence for the attributable burden of respiratory infections in China\u2019s population under 20: Challenges from particulate matter pollution","author":"Duan","year":"2024","journal-title":"Environ Health"},{"key":"R24-20260205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/eurpub\/ckq120","article-title":"The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival","volume":"21","author":"Asadzadeh Vostakolaei","year":"2011","journal-title":"Eur J Public Health"},{"key":"R25-20260205","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R26-20260205","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: An analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Pub Health"},{"key":"R27-20260205","first-page":"55","article-title":"National age-specific mortality trends for cervical and breast cancers in urban\u2013rural areas of China from 2009 to 2021: A population-based analysis","volume":"11","author":"Li","year":"2024","journal-title":"Mil Med Res"},{"key":"R29-20260205","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Nat Cancer Cent"},{"key":"R30-20260205","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","article-title":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the Global Burden of Disease Study 2015","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R31-20260205","doi-asserted-by":"crossref","DOI":"10.1177\/1557988319856739","article-title":"Associations between masculine norms and health-care utilization in highly religious, heterosexual men","volume":"13","author":"Novak","year":"2019","journal-title":"Am J Mens Health"},{"key":"R32-20260205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1470-2045(21)00279-5","article-title":"Global burden of cancer in 2020 attributable to alcohol consumption: A population-based study","volume":"22","author":"Rumgay","year":"2021","journal-title":"Lancet Oncol"},{"key":"R33-20260205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","article-title":"Cigarette smoking and liver diseases","volume":"77","author":"Marti-Aguado","year":"2022","journal-title":"J Hepatol"},{"key":"R34-20260205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28544","article-title":"Association between changes in alcohol consumption and cancer risk","volume":"5","author":"Yoo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R35-20260205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40572-021-00330-8","article-title":"Sex and gender differences in occupational hazard exposures: A scoping review of the recent literature","volume":"8","author":"Biswas","year":"2021","journal-title":"Curr Environ Health Rep"},{"key":"R36-20260205","doi-asserted-by":"crossref","first-page":"23416","DOI":"10.18632\/aging.203620","article-title":"Impact of aging on primary liver cancer: Epidemiology, pathogenesis and therapeutics","volume":"13","author":"Macias","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R37-20260205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.46234\/ccdcw2021.158","article-title":"Trends and challenges for population and health during population aging - China, 2015\u20132050","volume":"3","author":"Luo","year":"2021","journal-title":"China CDC Wkly"},{"key":"R38-20260205","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/ijms24032409","article-title":"Primary liver cancers: Connecting the Dots of cellular studies and epidemiology with metabolomics","volume":"24","author":"Berkemeyer","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R39-20260205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5718","article-title":"Associations between hepatitis B virus infection and risk of all cancer types","volume":"2","author":"Song","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R40-20260205","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R41-20260205","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854530","article-title":"Role of sex hormones in the development and progression of hepatitis B virus-associated hepatocellular carcinoma","volume":"2015","author":"Montella","year":"2015","journal-title":"Int J Endocrinol"},{"key":"R42-20260205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R43-20260205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"R44-20260205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: Facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep"},{"key":"R45-20260205","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102765","article-title":"Worldwide burden of liver cancer across childhood and adolescence, 2000-2021: A systematic analysis of the Global Burden of Disease Study 2021","volume":"75","author":"Wu","year":"2024","journal-title":"EClinicalMedicine"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:01:15Z","timestamp":1770267675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003828","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"2024-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}